| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Recruiting | Immune Profile and Complication Risk in Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | ||||||
| 2 | Recruiting | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: nitroprusside, pentalong, imdur, AICAR, isoptin | |||||
| 3 | Recruiting | An Efficacy and Safety Study of TAK-379 in Treating Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: 25 mg TAK-379; Drug: 100 mg TAK-379; Drug: 200 mg TAK-379; Drug: 30 mg ACTOS®; Drug: Placebo | |||||
| 4 | Recruiting | Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise | ||||
| Conditions: | Diabetes Mellitus, Type 2; Overweight | |||||
| Intervention: | Behavioral: Aerobic exercise program - 8 weeks | |||||
| 5 | Recruiting | Assessment of the Skin-Concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Vildagliptin; Drug: Vildagliptin | |||||
| 6 | Recruiting | Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study | ||||
| Conditions: | Diabetes Mellitus, Type 2; Insulin Resistance; Obesity | |||||
| Interventions: | Procedure: Duodenal exclusion plus omentectomy; Procedure: Duodenal exclusion without omentectomy | |||||
| 7 | Not yet recruiting | The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: Lipoic acid | |||||
| 8 | Recruiting | A Phase IIa Proof-of-Concept Study of NC-503 in Patients With Type II Diabetes | ||||
| Conditions: | Diabetes Mellitus, Type 2; Metabolic Syndrome X | |||||
| Interventions: | Drug: NC-503 (eprodisate disodium); Other: placebo | |||||
| 9 | Recruiting | Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus | ||||
| Conditions: | Obesity; Insulin Resistance; Overweight; Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Metformin; Drug: Insulin; Drug: Diazoxide; Behavioral: Nutrition counseling; Behavioral: Exercise counseling | |||||
| 10 | Recruiting | A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: LY2189265; Drug: Sitagliptin 100mg, 24 months; Drug: Placebo solution; Drug: Placebo tablet, 6 months; Drug: Placebo tablet, 24 months; Drug: Sitagliptin 100 mg, 18 months | |||||
| 11 | Recruiting | Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM) | ||||
| Conditions: | Kidney Transplant; Diabetes Mellitus, Type 2; Diabetic Nephropathy | |||||
| Interventions: | Drug: Cyclosporin; Drug: Tacrolimus; Behavioral: Diabetes Education / Management | |||||
| 12 | Recruiting | Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: Balaglitazone | |||||
| 13 | Recruiting | A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin | ||||
| Conditions: | Non-Insulin-Dependent Diabetes Mellitus; Type 2 Diabetes | |||||
| Intervention: | Drug: Rosiglitazone maleate/metformin hydrochloride (AVANDAMET) | |||||
| 14 | Recruiting | Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: Vildagliptin | |||||
| 15 | Recruiting | Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Vildagliptin; Drug: Placebo | |||||
| 16 | Recruiting | Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%) | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: vildagliptin, metformin; Drug: metformin | |||||
| 17 | Recruiting | Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Other: Nutritional Formula; Other: Usual diet; Other: Diabetes Meal Plan with experimental diabetes-specific nutritional shake, diabetes specific cereal, and diabetes specific snack bars. | |||||
| 18 | Recruiting | Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: insulin detemir | |||||
| 19 | Recruiting | Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: insulin | |||||
| 20 | Recruiting | Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: biphasic insulin aspart 30 | |||||
| 21 | Recruiting | Episodic Intensive Blood Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Device: AccuChek Aviva Meter with use of Accu-Chek 360 view blood glucose analysis system | |||||
| 22 | Recruiting | Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: EX1000; Drug: biphasic human insulin | |||||
| 23 | Recruiting | Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: insulin detemir; Drug: insulin NPH | |||||
| 24 | Recruiting | Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: insulin detemir | |||||
| 25 | Recruiting | Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: insulin detemir | |||||
| 26 | Recruiting | A Trial in Type 2 Diabetes Comparing NN9535 to Placebo and Liraglutide | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: NN9535; Drug: NN9535; Drug: NN9535; Drug: NN9535; Drug: NN9535; Drug: NN9535; Drug: placebo; Drug: placebo; Drug: placebo; Drug: placebo; Drug: placebo; Drug: placebo; Drug: liraglutide; Drug: liraglutide | |||||
| 27 | Recruiting | Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: rimonabant (SR141716); Drug: placebo | |||||
| 28 | Recruiting | Effect of PF-00734200 in Subjects With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: PF-00734200 30 mg QD; Drug: PF-00734200 20 mg QD; Drug: Placebo | |||||
| 29 | Recruiting | A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Insulin Glargine; Drug: Insulin Lispro Protamine Suspension | |||||
| 30 | Recruiting | The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: liraglutide; Drug: placebo; Drug: glimepiride | |||||
| 31 | Recruiting | BI 10773 Add-on to Metformin in Patients With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: BI 10773; Drug: placebo; Drug: sitagliptin | |||||
| 32 | Not yet recruiting | Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: rimonabant (SR141716); Drug: metformin; Drug: placebo | |||||
| 33 | Recruiting | A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: MK0893; Drug: Comparator: sitagliptin phosphate; Drug: Comparator: Metformin hydrochloride; Drug: Comparator: Placebo (Unspecified) | |||||
| 34 | Recruiting | Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: insulin detemir | |||||
| 35 | Recruiting | Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Insulin Lispro Protamine Suspension; Drug: Insulin Glargine | |||||
| 36 | Recruiting | Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Benfotiamine; Drug: Placebo | |||||
| 37 | Recruiting | Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Device: AccuChek Aviva Meter; Device: AccuChek Aviva Meter | |||||
| 38 | Recruiting | The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: liraglutide; Drug: sitagliptin; Drug: metformin; Drug: liraglutide | |||||
| 39 | Recruiting | Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-Diabetic Agents | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: soluble human insulin; Drug: biphasic human insulin; Drug: insulin NPH; Drug: insulin aspart; Drug: biphasic insulin aspart; Drug: insulin detemir | |||||
| 40 | Recruiting | Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: biphasic insulin aspart 30; Drug: metformin | |||||
| 41 | Recruiting | A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: TT223; Drug: Placebo | |||||
| 42 | Recruiting | Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Insulin Glargine; Drug: Insulin Lispro Premix (mid-mixture and low-mixture) | |||||
| 43 | Recruiting | A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus. | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: RO4998452; Drug: placebo | |||||
| 44 | Recruiting | Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir). | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Intervention: | Drug: insulin detemir | |||||
| 45 | Recruiting | REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Rimonabant; Drug: Placebo | |||||
| 46 | Recruiting | GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: AVE0010; Drug: Placebo | |||||
| 47 | Recruiting | This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: Inhaled Insulin (Exubera); Drug: insulin glargine | |||||
| 48 | Recruiting | A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both. | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: taspoglutide; Drug: taspoglutide; Drug: exenatide | |||||
| 49 | Recruiting | A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise. | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: taspoglutide; Drug: taspoglutide; Drug: placebo | |||||
| 50 | Recruiting | A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin. | ||||
| Condition: | Diabetes Mellitus, Type 2 | |||||
| Interventions: | Drug: taspoglutide; Drug: taspoglutide; Drug: sitagliptin; Drug: placebo; Drug: metformin; Drug: placebo | |||||
| Studies Shown (1-50) | Next (51-100) |  |
|
